Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$36.36 USD
+0.39 (1.08%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $36.15 -0.21 (-0.58%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (87 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.35 | 9.99 |
Current Quarter Estimate | -2.40 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -15.00 | 0.12 | 54.84 |
Next Quarter Estimate | -2.34 | 7.81 | 63.00 |
Next Year Estimate | -10.73 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 81.84 | 17.80 | 15.67 |
Next Year | -11.31 | 17.20 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 22.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.91 | 1.47 |
Price/Cash Flow (MRFY) | NA | 8.80 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -35.91% |
Return on Equity (TTM) | -80.45% | -39.73% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.